Zoe Rogers

Research Assistant

Phone: 0113 2068504
Email: z.a.rogers@leeds.ac.uk

 

Zoe joined the group in October 2014 and is involved in the Randomised Controlled Trial (RCT) of the eRAPID system, recruiting and training patients and staff in the use of eRAPID to self-report adverse events (AE) during and after cancer treatment. Before joining the group, Zoe worked for the Epidemiology and Biostatistics section of LICAP on the data analysis and write-up of a study to identify psychosocial risk factors for worry in a large cohort of melanoma patients. Prior to this, Zoe was the lead Research Assistant for the Lancashire area of the BeneMin trial: The Benefit of Minocycline on the Negative Syndrome of Psychosis (UKCRN ID: 10411), and was responsible for the recruitment of patients from Early Intervention Services across the Trust. Her other research experience includes  working at the Glasgow Sleep Centre on studies of the persistence of insomnia in breast cancer patients and in the general population.

 

Research Interests

Zoe’s main academic interests lie in clinical and health psychology.

 

Presentations and Publications

  • Holmes M, Rogers Z, Davidson S, Routledge J, Henry A, Franks K, Gilbert A, Velikova G. (March 2016) Seeking consensus from staff and patients on appropriate patient-reported outcome (PRO) items for radical prostate patients in the eRAPID (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) project: a Delphi study. In The British Psychosocial Oncology Society’s (BPOS) Annual Conference Vol. 25. pp 1-22. Cambridge: Psycho-Oncology
  • Holmes M, Holch P, Rogers Z, Dickinson S, Davidson S, Routledge J, Henry A, Franks K, Gilbert A, Velikova G. (March 2016) Patient and relatives attitudes to the implementation of eRAPID (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) during and after pelvic radiotherapy: A qualitative interview study. In The British Psychosocial Oncology Society’s (BPOS) Annual Conference. Vol. 25 pp 1-22. Cambridge: Psycho-Oncology
  • Rogers Z, Holch P, Holmes M, Davidson S, Routledge J, Henry A, Franks K, Gilbert A, Dickinson S, Velikova G. (March 2016) Healthcare Professional (HCP) attitudes to the implementation of eRAPID (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) during and after pelvic radiotherapy: A qualitative interview study. In The British Psychosocial Oncology Society’s (BPOS) Annual Conference Vol. 25. pp 1-22. Cambridge: Psycho-Oncology
  • Warrington L, Absolom K, Holmes M, Rogers Z, Gibson A, Clayton B, Holch P, Carter R, Kellar I, Conner M, Velikova G (2016) Does the Patient Activation Measure (PAM) predict engagement with an online system for patients to report and manage symptoms during and after cancer treatment? In The British Psychosocial Oncology Society’s (BPOS) Annual Conference. Cambridge
  • Gibson A., Absolom K, Warrington L, Holch T, Holmes M, Clayton B, Rogers Z, Velikova G. (June 2015) An Overview of eRAPID: electronic patient self-Reporting of Adverse-events: Patient Information and aDvice. A Randomised controlled trial in systemic cancer treatment. In UK Clinical Trials Conference for Supportive Care in Cancer Research. Sheffield
  • Rogers Z, Elliott F, Kasparian N, Barrett JH, Bishop DT, Newton-Bishop J (2014) Psychosocial, clinical and demographic features of worry related to melanoma. In GenoMel/BIOGenoMel Conference. Valencia
  • Kyle SD, Beattie L, Spiegelhalder K., Rogers Z, Espie CA. (2014) Altered emotion perception in insomnia disorder. Sleep 37(4)
  • Kyle SD, Miller CB, Rogers Z, Siriwardena AN, MacMahon KM, Espie CA (2014) Sleep Restriction Therapy for Insomnia is Associated with Reduced Objective Total Sleep Time, Increased Daytime Somnolence, and Objectively Impaired Vigilance: Implications for the Clinical Management of Insomnia Disorder. Sleep 37(2): 229-237
  • Rogers Z, Biello S, Gardani M (2012) Reduced sleep quality predicts lower self-esteem. In European Sleep Research Society. Paris